Department of Dentistry, Pokhara Academy of Health Sciences, Ramghat 10, Nepal.
Department of Oral Medicine and Radiology, College of Dental Surgery, B.P. Koirala Institute of Health Science, Dharan 18, Nepal.
Oral Oncol. 2021 Jul;118:105312. doi: 10.1016/j.oraloncology.2021.105312. Epub 2021 May 20.
To evaluate diagnostic efficacy of Identafi® and toluidine blue in screening of Oral Potentially Malignant Disorders (OPMDs).
Forty nine patients (63 lesions) with OPMDs visiting Department of Oral Medicine and Radiology, B.P.Koirala Institute of Health Science (BPKIHS) were included in the study. After thorough history and oral examination, screening was done by Identafi® followed by toluidine blue staining. Then incisional biopsy under local anesthesia was performed from the site showing positive change followed by histopathological examination.
The overall sensitivity and specificity of Identafi®s violet light was 73% and 46.2%. The overall sensitivity and specificity of Identafi®s green-amber light were 78.4% and 15.4% respectively. The overall sensitivity and specificity of toluidine blue were 51.4 and 84.6 respectively. A statistically-significant association was observed between the toluidine blue and histopathology results, (p = 0.04), p value set at ≤ 0.05.
Identafi®'s violet light and green amber light are more sensitive in detecting true positives. Toluidine blue is highly specific in ruling out true negative cases. The screening of OPMDs will help in selecting proper biopsy site followed by early diagnosis and intervention, hence increasing the prognosis, outcome and decrease complications associated with it.
评估 Identafi® 和甲苯胺蓝在口腔潜在恶性疾病(OPMDs)筛查中的诊断效能。
本研究纳入了在尼泊尔 BPKIHS 口腔医学和放射科就诊的 49 名 OPMD 患者(63 处病变)。在进行详细的病史询问和口腔检查后,首先使用 Identafi® 进行筛查,然后进行甲苯胺蓝染色。随后,在局麻下对显示阳性变化的部位进行切取活检,并进行组织病理学检查。
Identafi® 紫光的总体敏感性和特异性分别为 73%和 46.2%。Identafi® 绿光的总体敏感性和特异性分别为 78.4%和 15.4%。甲苯胺蓝的总体敏感性和特异性分别为 51.4%和 84.6%。甲苯胺蓝与组织病理学结果之间存在统计学显著关联(p=0.04),p 值设定为≤0.05。
Identafi® 的紫光和绿光在检测真正的阳性病例时更敏感。甲苯胺蓝在排除真正的阴性病例时具有高度特异性。OPMDs 的筛查有助于选择适当的活检部位,从而实现早期诊断和干预,提高预后、结果,并降低与之相关的并发症。